Nektar Therapeutics
Develops investigational immune-modulating medicines for autoimmune disease and cancer.
$72.50
After-hours close−0.04 (−0.06%)
At close$72.54(−2.70%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.26 | — | — |
| Aug 2026 | −$1.97 | −$1.23 | +37.6% |
| May 2026 | −$1.58 | −$1.82 | −15.0% |
| Mar 2026 | −$2.76 | −$1.78 | +35.5% |
| Nov 2025 | −$2.85 | −$1.85 | +35.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$2.26 | — | — | $10.4M | — | — |
| Aug 13, 2026 | −$1.97 | −$1.23 | +37.6% | $10.4M | $10.1M | −2.8% |
| May 7, 2026 | −$1.58 | −$1.82 | −15.0% | $10.7M | $10.9M | +1.6% |
| Mar 12, 2026 | −$2.76 | −$1.78 | +35.5% | $10.2M | $21.8M | +114.0% |
| Nov 6, 2025 | −$2.85 | −$1.85 | +35.1% | $10.4M | $11.8M | +12.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 12, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 4, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 27, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 8, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 1, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 1, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 3, 2016 | ||||||
| Mar 1, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 5, 2015 | ||||||